6-30914857-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_020442.6(VARS2):​c.21C>T​(p.Ala7Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.334 in 1,612,758 control chromosomes in the GnomAD database, including 93,516 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.28 ( 6828 hom., cov: 32)
Exomes 𝑓: 0.34 ( 86688 hom. )

Consequence

VARS2
NM_020442.6 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.184

Publications

32 publications found
Variant links:
Genes affected
VARS2 (HGNC:21642): (valyl-tRNA synthetase 2, mitochondrial) This gene encodes a mitochondrial aminoacyl-tRNA synthetase, which catalyzes the attachment of valine to tRNA(Val) for mitochondrial translation. Mutations in this gene cause combined oxidative phosphorylation deficiency-20, and are also associated with early-onset mitochondrial encephalopathies. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Aug 2014]
VARS2 Gene-Disease associations (from GenCC):
  • mitochondrial disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • combined oxidative phosphorylation defect type 20
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 6-30914857-C-T is Benign according to our data. Variant chr6-30914857-C-T is described in ClinVar as [Benign]. Clinvar id is 380149.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.184 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.358 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VARS2NM_020442.6 linkc.21C>T p.Ala7Ala synonymous_variant Exon 2 of 30 ENST00000676266.1 NP_065175.4 Q5ST30-1B4E0K6B4DG77
VARS2NM_001167734.2 linkc.111C>T p.Ala37Ala synonymous_variant Exon 2 of 30 NP_001161206.1 Q5ST30-4A0A1U9X9B3
VARS2NM_001167733.3 linkc.-219-299C>T intron_variant Intron 1 of 28 NP_001161205.1 Q5ST30-3B4E0K6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VARS2ENST00000676266.1 linkc.21C>T p.Ala7Ala synonymous_variant Exon 2 of 30 NM_020442.6 ENSP00000502585.1 Q5ST30-1

Frequencies

GnomAD3 genomes
AF:
0.280
AC:
42528
AN:
151942
Hom.:
6831
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.124
Gnomad AMI
AF:
0.308
Gnomad AMR
AF:
0.242
Gnomad ASJ
AF:
0.401
Gnomad EAS
AF:
0.254
Gnomad SAS
AF:
0.264
Gnomad FIN
AF:
0.392
Gnomad MID
AF:
0.379
Gnomad NFE
AF:
0.362
Gnomad OTH
AF:
0.283
GnomAD2 exomes
AF:
0.316
AC:
77929
AN:
246428
AF XY:
0.324
show subpopulations
Gnomad AFR exome
AF:
0.120
Gnomad AMR exome
AF:
0.218
Gnomad ASJ exome
AF:
0.381
Gnomad EAS exome
AF:
0.283
Gnomad FIN exome
AF:
0.392
Gnomad NFE exome
AF:
0.369
Gnomad OTH exome
AF:
0.334
GnomAD4 exome
AF:
0.339
AC:
495673
AN:
1460696
Hom.:
86688
Cov.:
60
AF XY:
0.339
AC XY:
246474
AN XY:
726678
show subpopulations
African (AFR)
AF:
0.116
AC:
3867
AN:
33480
American (AMR)
AF:
0.220
AC:
9839
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.375
AC:
9794
AN:
26136
East Asian (EAS)
AF:
0.241
AC:
9552
AN:
39698
South Asian (SAS)
AF:
0.276
AC:
23791
AN:
86254
European-Finnish (FIN)
AF:
0.386
AC:
20172
AN:
52294
Middle Eastern (MID)
AF:
0.330
AC:
1901
AN:
5768
European-Non Finnish (NFE)
AF:
0.358
AC:
397958
AN:
1111962
Other (OTH)
AF:
0.311
AC:
18799
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
19467
38933
58400
77866
97333
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12422
24844
37266
49688
62110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.280
AC:
42538
AN:
152062
Hom.:
6828
Cov.:
32
AF XY:
0.281
AC XY:
20858
AN XY:
74316
show subpopulations
African (AFR)
AF:
0.124
AC:
5164
AN:
41498
American (AMR)
AF:
0.242
AC:
3704
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.401
AC:
1392
AN:
3472
East Asian (EAS)
AF:
0.254
AC:
1310
AN:
5166
South Asian (SAS)
AF:
0.263
AC:
1265
AN:
4816
European-Finnish (FIN)
AF:
0.392
AC:
4130
AN:
10548
Middle Eastern (MID)
AF:
0.378
AC:
111
AN:
294
European-Non Finnish (NFE)
AF:
0.362
AC:
24591
AN:
67962
Other (OTH)
AF:
0.280
AC:
590
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1512
3025
4537
6050
7562
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
442
884
1326
1768
2210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.334
Hom.:
16030
Bravo
AF:
0.263
Asia WGS
AF:
0.207
AC:
724
AN:
3478
EpiCase
AF:
0.369
EpiControl
AF:
0.372

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Jul 31, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 48% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy, Progressive Myoclonus Epilepsy and Abnormal Movements and Neurodegeneration with brain iron accumulation. Number of patients: 45. Only high quality variants are reported. -

Dec 16, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 19, 2016
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.63
CADD
Benign
9.3
DANN
Benign
0.90
PhyloP100
-0.18
PromoterAI
0.018
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1264302; hg19: chr6-30882634; COSMIC: COSV52558947; COSMIC: COSV52558947; API